Sarcoma  >>  Immunotherapy  >>  Phase 2


«123»
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 08162432404856647280
            
            
             
indoximod (NLG8189) / Lumos Pharma           
          
            
             
izuralimab (XmAb23104) / Xencor           
          
            
             
mipetresgene autoleucel (TBI-1301) / Takara           
          
            
             
nintedanib / Generic mfg.           
          
            
             
relatlimab (BMS-986016) / BMS, Ono Pharma           
          
            
             
zalifrelimab (UGN-301) / UroGen           
          
            
             
zanidatamab (ZW25) / Jazz           
          
            
             
Aibining (geptanolimab) / Apollomics           
          
            
             
AlloStim (bioengineered allogeneic immune cells) / Immunovative           
          
            
             
Autologous dendritic cell vaccine / N.N. Petrov National Medical Research Center of Oncology           
          
            
             
Blincyto (blinatumomab) / Astellas, Amgen           
          
            
             
BrevaRex (AR20.5) / CanariaBio           
          
            
             
DCVax-L (autologous dendritic cell vaccine leaded with autologous tumor cell lysate) / Northwest Biotherap           
          
            
             
EGFR bi-armed autologous activated T cells / Barbara Ann Karmanos Cancer Institute           
          
            
             
EIK1001 / Eikon Therap           
          
            
             
GI-101 / GI Innovation           
          
            
             
GSK5764227 / GSK           
          
            
             
H1299 cell lysate with iscomatrix adjuvant vaccine / National Cancer Institute           
          
            
             
IMC-C103C / Immunocore, Roche           
          
            
             
Imunace (teceleukin) / Shionogi           
          
            
             
LN-145 / Iovance Biotherap           
          
            
             
MDA-TIL / Iovance Biotherap, UT MD Anderson Cancer Center           
          
            
             
MHB088C / Minghui Pharma           
          
            
             
Mylotarg (gemtuzumab ozogamicin) / UCB, PDL, Pfizer           
          
            
             
NKTR-262 / Nektar Therap           
          
            
             
Oncopore (ruxotemitide) / Verrica           
          
            
             
PDS01ADC / PDS Biotech           
          
            
             
PSMA ADC / Lantheus           
          
            
             
Puyouheng (pucotenlimab) / Taizhou Hanzhong Biopharma, Lepu Med           
          
            
             
Sitoiganap (ERC1671) / Epitopoietic Research Corp           
          
            
             
VG161 / ViroGin Biotech           
          
            
             
Vonjo (pacritinib) / SOBI           
          
            
             
darleukin (L19IL2) / Philogen           
          
            
             
datopotamab deruxtecan (DS-1062a) / Daiichi Sankyo, AstraZeneca           
          
            
             
drozitumab (RG7425) / Roche           
          
            
             
etrumadenant (AB928) / Arcus Biosci, Gilead           
          
            
             
fianlimab (REGN3767) / Regeneron           
          
            
             
gotistobart (BNT316) / OncoC4, BioNTech           
          
            
             
ieramilimab (LAG525) / Novartis           
          
            
             
ifinatamab deruxtecan (DS-7300) / Daiichi Sankyo, Merck (MSD)           
          
            
             
linrodostat (BMS-986205) / BMS, Ono Pharma           
          
            
             
nelitolimod (SD-101) / TriSalus Life Sci, UT MD Anderson Cancer Center           
          
            
             
oleclumab (MEDI9447) / AstraZeneca           
          
            
             
ontorpacept (PF-07901800) / Pfizer           
          
            
             
racemetyrosine (SM-88) / Syros           
          
            
             
sotigalimab (PYX-107) / Pyxis Oncology           
          
            
             
tinengotinib (TT-00420) / TransThera Biosci           
          
            
             
tiragolumab (RG6058) / Roche           
          
            
             
trivalent ganglioside vaccine / MabVax           
          
            
             
voriconazole / Generic mfg.           
          
            
            


«123»